Accelerates your best scientists
Kosmos increases the probability of success while reducing development timelines across the full R&D pipeline.
Drive scientific investigations
Reads literature, analyzes data, generates hypotheses, steers investigations mid-run, branches hypotheses, and executes scientific workflows autonomously
Support the full lifecycle of drug development
Executes workflows from target identification through clinical development and filing
Embed in your scientists' workstreams
Collaborates through Slack, Teams, and email while Kosmos advances investigations and surfaces findings
Learn from your organization's knowledge
Builds on your experimental history, decision patterns, and proprietary scientific data across
Leverage the best frontier models
Remains model agnostic as new state-of-the-art models emerge
“By using systems that learn from our experimental and clinical data, we can enhance result interpretation, creating a feedback loop that boosts both speed and quality in future programs.”
Patrick Mayes
Executive Vice President and Chief Scientific Officer
By scientists, for scientists
Edison Scientific is run by scientists and engineers from leading institutions and labs across physics, biology, chemistry, and AI.
“Within 24 hours, at a fraction of the equivalent human cost, Kosmos executed roughly 292 independent analysis trajectories — work that revealed insights our human team had missed despite weeks of analysis.”
Tonio Buonassisi
Professor of Mechanical Engineering
On prem platform
We are SOC2 Type II compliant. Fully secure, deployed in your environment, so you have full governance and can retain model training only as it serves you.
Forward-deployed scientists
Embedded in your team, our experts work collaboratively with your scientists.
Custom world models
Developed on top of your data and integrating information across your organization.
Trusted by leading biopharma organizations and academic institutions
Featured news
Announcement
Building AI-Native Biopharma: Announcing Our Partnership with Incyte Corporation and Kosmos for R&D Teams
May 19, 2026
Announcement
Building AI-Native Biopharma: Announcing Our Partnership with Incyte Corporation and Kosmos for R&D Teams
May 19, 2026
